INVO BIOSCIENCE INC (OTCMKTS:IVOB) Shorted Shares Increased 300% After Market Selling

INVO Bioscience, Inc. (OTCMKTS:IVOB) Logo

The stock of INVO BIOSCIENCE INC (OTCMKTS:IVOB) registered an increase of 300% in short interest. IVOB’s total short interest was 14,800 shares in October as published by FINRA. Its up 300% from 3,700 shares, reported previously. With 78,800 shares average volume, it will take short sellers 0 days to cover their IVOB’s short positions.

The stock increased 3.33% or $0.01 during the last trading session, reaching $0.31. About 69,843 shares traded or 58.40% up from the average. INVO Bioscience, Inc. (OTCMKTS:IVOB) has 0.00% since October 12, 2018 and is . It has by 0.00% the S&P500.

INVO Bioscience, Inc., a medical device company, provides novel solutions in assisted reproductive technologies to the reproductive health care community in the United States, Canada, South and Central America, Latin America, India, the Middle East, and Africa. The company has market cap of $48.22 million. The firm offers the INVOcell device that is used in infertility treatment for the incubation of eggs and sperm during fertilization, and early embryo development. It currently has negative earnings. It also offers INVO procedure, an alternative infertility treatment that enables the conception and embryo development inside the womanÂ’s body.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.